Biotechnology Company Announces U.S. FDA Grants For Alzheimer's Disease Treatment
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for Mild Alzheimer's Disease.
Disclaimer: The information provided in this article is for informational purposes only and should not be construed as medical or professional advice. Always consult with a healthcare provider for medical advice and treatment options.
Real-time information is available daily at https://stockregion.net